Fifth Street Finance Corp. Appoints James Castro-Blanco to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Fifth Street Finance Corp. Appoints James Castro-Blanco to the Board of Directors

GREENWICH, CT, Aug. 18, 2014 (GLOBE NEWSWIRE) -- Fifth Street Finance Corp. (NASDAQ: FSC ) ("FSC") today announced that James Castro-Blanco has been appointed as an independent director, effective August 15, 2014. His appointment brings the Board of Directors back to eight directors, five of whom are independent.

"We are pleased to add Jim to FSC's Board of Directors. With over 20 years of experience as an attorney in both the private and public sectors, we believe that he will provide a valuable perspective to our Board of Directors," stated FSC's Chief Executive Officer, Leonard M. Tannenbaum.

Mr. Castro-Blanco serves as the Chief Deputy County Attorney for Westchester County, where he advises numerous elected officials, boards and commissions and, since December 2010, has been a lead attorney on high profile matters involving Westchester County. Prior experiences include providing business and risk management advice to businesses and individuals as well as investigating and reporting alleged financial improprieties. He has also been a former Assistant United States Attorney where he investigated and prosecuted individuals and organizations involved in RICO, money-laundering and other financial crimes. In addition, he has past experience working on antitrust and complex corporate litigation matters. 

Mr. Castro-Blanco graduated with a J.D. from Brooklyn Law School where he was the articles editor of the Law Review. Mr. Castro-Blanco also holds a B.A. from the State University of New York at Albany. Mr. Castro-Blanco has served on the board of trustees for St. John's Riverside Hospital and is the chair of the Liability Committee, helping guide the institution through the myriad changes in today's healthcare environment. He has also been a board member of several charities providing scholarship monies to deserving students and has served as the president of the largest Hispanic bar association on the East Coast of the United States.

About Fifth Street Finance Corp.

Fifth Street Finance Corp. is a leading specialty finance company that provides custom-tailored financing solutions to mid-sized companies, primarily in connection with investments by private equity sponsors. The company originates and invests in one-stop financings, first lien, second lien, mezzanine debt and equity co-investments. FSC's investment objective is to maximize its portfolio's total return by generating current income from its debt investments and capital appreciation from its equity investments. The company has elected to be regulated as a business development company and is externally managed by Fifth Street Management LLC, an SEC-registered investment adviser and leading alternative asset manager with $5 billion in assets under management. With a track record of more than 16 years, Fifth Street's nationally recognized platform has the ability to hold loans up to $150 million, commit up to $250 million and structure and syndicate transactions up to $500 million.  Fifth Street Management received the 2014 ACG New York Champion's Award for "Senior Lender Firm of the Year" and was named both 2013 "Lender Firm of the Year" by The M&A Advisor and "Lender of the Year" by Mergers & Acquisitions . FSC's website can be found at fsc.fifthstreetfinance.com.

Forward-Looking Statements

This press release may contain certain forward-looking statements, including statements with regard to the future performance of the company. Words such as "believes," "expects," "estimates," "projects," "anticipates," and "future" or similar expressions are intended to identify forward-looking statements. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. Certain factors could cause actual results to differ materially from those projected in these forward-looking statements, and these factors are identified from time to time in the company's filings with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Contact: Robyn Friedman, Vice President, Investor Relations (203) 681-3720 Media Contact: Nick Rust Prosek Partners (212) 279-3115 ext. 252

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BYD's Chip Mastery Amid China's Auto Supply Tensions

Updated Category News Views 2

Chips, the New Battleground in Automotive Innovation Here we are, folks, knee-deep in a tech-driven car revolution where semiconductors aren't just the icing on the cake—they're the cake itself. As vehicles morph into veritable computers on wheels, reliance on chips is hitting a fever pitch. FYI, it's not just about making cars go; we're talking power management,...

Continue Reading
Midea's VitaBreeze: Revolutionizing Personalized Climate

Updated Category News Views 7

A Fresh Breeze in Climate Control Here's something that'll shake up your household. Midea just announced their latest gizmo, called VitaBreeze, and they’re not messing around. They introduced it at IFA 2026, promising it's not just for cooling off in the summer or heating in the winter. Oh no, my friends, they've packed this unit with enough cutting-edge tech that...

Continue Reading
ISO 45010: First Guidance for Menstruation, Menopause

Updated Category News Views 2

Tackling Menstruation and Menopause in the Workplace Today, the International Organization for Standardization (ISO) has taken a bold step forward by launching ISO 45010—a groundbreaking standard aimed at addressing menstruation and menopause in the workplace. Millions endure these natural processes throughout their careers, yet structured policies to support them have...

Continue Reading
Pudu D7 Robot Shines at IFA, Setting New Robotics Bar

Updated Category News Views 3

Breaking New Ground in Robotics at IFA Well, here's a nugget for robotics buffs and investors alike: Pudu Robotics, a heavyweight in commercial service robotics, is carving out a fresh chapter with its PUDU D7. Making waves as an honoree at the IFA Innovation Awards, the D7 presents a mash-up of brains and brawn—exemplifying the future path for robotics. The PUDU D7...

Continue Reading
Hyundai and UEFA: Kicking Off a Game-Changing Deal

Updated Category News Views 3

Hyundai Drives Into Europe's Football Arena Football fever just turned electric with Hyundai allying itself with the UEFA Champions League. We're not talking about sidelines. We're smack dab in the center field of a multi-year partnership starting with the 2026/27 season. Folks, if you think this is just Hyundai shaking hands for brand exposure, think again. This is...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 4

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
York Space Systems Faces Class Action Over Misleading IPO

Updated Category News Views 2

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

Continue Reading
TCL’s AI Vision: Immersive Living at IFA 2026

Updated Category News Views 3

AI and Displays: A Match Made in Tech Heaven Every so often, a company stands up at a tech fair and gives a glimpse into the next chapter of living, as TCL did at IFA 2026. This time, they're not just talking about screens; they're weaving them into the fabric of everyday life alongside AI capabilities. From sporting arenas to your living room, it's a vision of what could...

Continue Reading

Top 5 Most Recently Viewed Articles

Lynkwell Boosts Growth with Strategic Investments in North America

Updated Category News Views 191

Lynkwell Amplifies Growth Plans for North American Expansion Lynkwell, a leading player in energy infrastructure, is set to embark on an exciting journey into 2025. With a focus on meeting the growing demands of the evolving electric vehicle (EV) market, Lynkwell is making significant investments to enhance its capabilities and expand its footprint across North America....

Continue Reading
Understanding the Recent Private Student Loan Trends and Insights

Updated Category News Views 197

Overview of Recent Trends in Private Student Loans In the recent semi-annual Private Student Loan Report released by Enterval Analytics, insights into the current status of private student loans reveal a stable repayment landscape. Since Enterval focuses on the private student loan market, their findings shed light on how borrowers are adapting their financial strategies...

Continue Reading
StemCyte's Groundbreaking RMAT Designation for Long COVID-19

Updated Category News Views 63

StemCyte's Major Achievement in Cord Blood Therapy StemCyte has made significant strides in regenerative medicine, specifically with its Hematopoietic Progenitor Cell (HPC) Cord Blood therapy. The company recently announced that it has received the Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) aimed at treating...

Continue Reading
Novo Nordisk Restructures to Combat Rising Competition

Updated Category News Views 214

Novo Nordisk's Significant Job Cuts Novo Nordisk, a leading pharmaceutical company in diabetes care, has announced a major workforce reduction, cutting 9,000 jobs, which amounts to about 11.5% of its employees. This decision reflects the intense market pressure the company faces from its competitor, Eli Lilly. Restructuring for Financial Efficiency The restructuring...

Continue Reading
One Helix: The Innovative Research Hub Transforming Life Sciences

Updated Category News Views 169

Elevating Research with One Helix One Helix emerges as a landmark project in life sciences, representing a new era of innovation and sustainable architecture. Located within a prominent university medical center, this facility is not just a building; it is a commitment to fostering scientific advancements. Completely leased to AstraZeneca, One Helix is designed to elevate...

Continue Reading